These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2290840)
1. Preclinical drug development in the antiepileptic drug development program. A cooperative effort of government and industry. Kupferberg HJ Prog Clin Biol Res; 1990; 361():113-30. PubMed ID: 2290840 [No Abstract] [Full Text] [Related]
2. The Antiepileptic Drug Development Program: an example of government-industry collaboration. White BG Prog Clin Biol Res; 1985; 197():83-93. PubMed ID: 4070302 [TBL] [Abstract][Full Text] [Related]
3. Advances in the clinical development of antiepileptic drugs. Porter RJ; Hessie BJ; Cereghino JJ; Gladding GD; Kupferberg HJ; Scoville B; White BG Fed Proc; 1985 Jul; 44(10):2645-9. PubMed ID: 3891417 [TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical industry screening for new antiepileptic drugs. Taylor CP; Marks JL Adv Neurol; 1998; 76():41-7. PubMed ID: 9408462 [TBL] [Abstract][Full Text] [Related]
6. The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. White HS; Wolf HH; Woodhead JH; Kupferberg HJ Adv Neurol; 1998; 76():29-39. PubMed ID: 9408461 [TBL] [Abstract][Full Text] [Related]
7. The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs. Castel-Branco MM; Alves GL; Figueiredo IV; Falcão AC; Caramona MM Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):101-6. PubMed ID: 19455265 [TBL] [Abstract][Full Text] [Related]
8. The preclinical new drug research program of the National Cancer Institute. Driscoll JS Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438 [TBL] [Abstract][Full Text] [Related]
9. History of the antiepileptic drugs. Swinyard EA Adv Neurol; 1980; 27():1-9. PubMed ID: 6990700 [No Abstract] [Full Text] [Related]
10. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods. Browne TR Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105 [No Abstract] [Full Text] [Related]
11. The pipeline for antiepileptic drugs. McKelvy JF Epilepsy Res Suppl; 1993; 10():3-8. PubMed ID: 8251104 [No Abstract] [Full Text] [Related]
12. Screening for anticonvulsant drugs. Am Pharm; 1980 Aug; NS20(8):57. PubMed ID: 7424782 [No Abstract] [Full Text] [Related]
13. US panel recommends major tuberculosis vaccine effort. Dove A Nat Med; 1998 Oct; 4(10):1097. PubMed ID: 9771727 [No Abstract] [Full Text] [Related]
15. Novel methods for studying new antiepileptic drug pharmacology. Mattson RH; Scheyer RD; Petroff OA; During MJ; Collins TL; Spencer D Adv Neurol; 1998; 76():105-12. PubMed ID: 9408467 [TBL] [Abstract][Full Text] [Related]
16. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry. Privitera M Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139 [TBL] [Abstract][Full Text] [Related]
17. The domestic drug regulatory process: why time is of the essence. Katz R Epilepsy Res Suppl; 1993; 10():91-106. PubMed ID: 8251109 [No Abstract] [Full Text] [Related]
18. The significance of mitochondrial toxicity testing in drug development. Dykens JA; Will Y Drug Discov Today; 2007 Sep; 12(17-18):777-85. PubMed ID: 17826691 [TBL] [Abstract][Full Text] [Related]
19. Promoting, improving and accelerating the drug development and approval processes. Graul AI Drug News Perspect; 2007; 20(1):45-55. PubMed ID: 17332899 [TBL] [Abstract][Full Text] [Related]
20. Antiepileptic drug development: I. History and a program for progress. Krall RL; Penry JK; Kupferberg HJ; Swinyard EA Epilepsia; 1978 Aug; 19(4):393-408. PubMed ID: 359324 [No Abstract] [Full Text] [Related] [Next] [New Search]